Valeant cuts 2016 revenue forecast Posted on April 13, 2016 by Deep Shares of Valeant Pharmaceuticals tumbled on Tuesday after the company cut its 2016 revenue forecast by about 12 percent and said a delay in filing its annual report could pose a debt default risk. The stock closed down more than Read More Valeant cuts 2016 revenue forecast